Aethlon Medical (AEMD) Registration filing summary

Risk factors and disclosures

• Independent auditor expressed substantial doubt about ability to continue as a going concern as of March 31, 2026 and 2025, highlighting financial uncertainty.

• Indemnification for directors and officers is provided under Nevada law and company bylaws, with insurance maintained for such liabilities.

• SEC may deem indemnification for Securities Act liabilities unenforceable as a matter of public policy.

Offering details and pricing

• Registration statement filed for a public offering, with securities to be offered as soon as practicable after effectiveness.

• Estimated total expenses for the offering are $450,381.52, including legal, accounting, and registration fees.

• Includes forms of common stock, pre-funded warrants, and placement agent warrants for the current offering.

Management team and governance

• CEO, CFO, and Chief Accounting Officer roles held by James B. Frakes, with additional directors listed.

• Executive and director compensation and employment agreements are in place, with recent amendments and awards disclosed.